Home page > Health, wealth and equity > Health friendly research and innovation

1/05/2013

EP resolution underlines the need for action on medicines access problem

On 18 April, the European Parliament (EP) voted on a Resolution on the impact of the financial and economic crisis on human rights. The resolution highlighted some of the global impacts of the crisis on the right to health. EPHA applauds the EP’s recognition of the multiple impacts of the crisis on ordinary people and the need to further champion public health across Europe. The Resolution states that "the rising price of medicines (by up to 30%) is having a negative impact on the (...)
5/03/2013

Ageing populations- Council conclusions on the sustainability of public finances

After the economic and financial affairs Council meeting, the Council has stated that in order to fight the economic and financial crisis and enhance sustainable growth, EU Member States have to ensure progress towards long-term fiscal sustainability of public finances. Further implementations of structural reforms should be done in accordance with the Europe 2020 strategy. According to positive developments related to life expectancy, more attention has to be paid to ageing population (...)
4/04/2013

Women and cervical cancer in the EU

On the occasion of the European Cervical Cancer Prevention Week, the European Institute of Women’s Health (EIWH), an EPHA member, presented its policy brief "Women and cervical cancer in the EU: promoting cervical cancer prevention" emphasising the need to reach a consensus across the European Union to put an end to the existing disparities between Member States. With 31 300 women developing the disease and 13 600 dying of it every year in the EU, cervical cancer remains the second (...)
4/02/2013

Revised Digital Agenda aims to boost economic growth and innovation

Following a comprehensive policy review, the European Commission published an updated Digital Agenda for Europe (DAE) on 18 December, which identifies seven new key areas to stimulate the conditions for creating growth and jobs in Europe. The focus is largely economic and eInclusion is not very pronounced, however it is hoped that in combination with the existing goals they can contribute to bridging the digital divide, especially for vulnerable groups and patients less likely or able to (...)
4/02/2013

Council conclusions on Healthy Ageing across the Lifecycle

The December meeting of the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) adopted a set of conclusions on Healthy Ageing. It asks for a rethink of health systems towards more prevention. The Council also calls for a new Alcohol Strategy, to replace the current mandate which endsed in 2012. Europe’s population is rapidly ageing, which is challenging, among others, pillars of welfare , pensions, and healthcare systemss. The 2012 European Year for active ageing (...)
11/12/2012

EPHA Position on Medical Devices Revision

Following the Commission proposals for a Regulation on Medical Devices and on In Vitro Medical Devices released in September 2012, EPHA has developed a position paper highlighting, inter alia, the importance of the provisions related to patient safety; the responsibilities of the notified bodies, and improved traceability. The EPHA Position on Medical Devices is supportive of the objectives - and legal format - of the Commission’s proposal which aims at ensuring a high level of human (...)
5/12/2012

CAMbrella urges coordinated approach to Complementary & Alternative Medicine (CAM) research

The final CAMbrella conference took place on 29 November 2012, showcasing the fruit of the 3-year pan-European CAM research project - the long-awaited ’’Roadmap for European CAM Research’’ that includes the findings of the work packages and provides conclusions and recommendations for a future research agenda. To kick off the conference, Dr. Wolfgang Weidenhammer, CAMbrella project coordinator based at University of Munich, recalled that CAMbrella is a so-called (...)
29/11/2012

Revised EPHA position on clinical trials

EPHA has revised its position on clinical trials following the European Commission’s release of a legislative proposal for a regulation over the summer. While the key elements remain the same, the updated version emphasises the need for clinical trials to go ahead so that different population groups can benefit from life-saving treatments, while underlining that patient safety must remain at the centre of the process, and not compromised by less rigid assessment procedures. The (...)
29/11/2012

Vivre l’Europe: Envisaging the future of European health systems

On 17 November, EPHA took part in a roundtable discussion as part of a conference entitled ’’Vivre l’Europe 2012 - Questions de sante en Europe’’, organised by the Maison de l’Europe in Nantes, France. The debate served to bring the debate over the challenges faced by European health systems closer to citizens, and it also crystallised the differences between the French health system and differing modalities in neighbouring countries. The first part of (...)
2/12/2012

Circular migration: Silver bullet or placebo solution?

Debates over circular migration to fill employment gaps in industrialised economies are of particular relevance to the health sector, where demographic change and concurrant increases in chronic diseases and multiple morbidities are driving an ever-greater need for qualified health professionals. However, a fine balance needs to be struck between migrants’ individual aspirations and the impact of their migration decision on health systems already hit by the effects of the crisis and (...)

0 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | ...